Narrow-moat-rated Repligen is a leading provider of bioprocessing solutions for companies that manufacture biologic drugs. Its business lines include advanced filtration and fluid management systems ...
Years of translational research have successfully improved treatment outcomes for common dermatological conditions such as ...
The Harding Loevner Chinese Equity composite fell 9.1% (gross) in Q4 2024, trailing the 6.9% fall of the MSCI China All ...
You will be redirected to our submission process. Radiolabeled biologics whether amino acids, cells, antibodies, proteins, viruses or synthetic ligands have potential for functional imaging and ...
The Department of Science and Technology (DOST) has launched eight transformative research and development (R&D) programs ...
Synthetic biologists from Yale were able to re-write the genetic code of an organism — a novel genomically recoded organism ...
NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company") is pleased to announce the formation of a U.S.-based ...
Under the agreement, the companies will advance development of IBI3009, Innovent’s ADC candidate, which has received IND approvals in the US, China, and Australia.
Precision medicines biotech Frontier Medicines is leaving behind an unknown number of staffers as it refocuses resources to optimize operations. The California-based company is streamlining its ...
Several male passengers tacked the man and tied him up for the rest of the flight. HOUSTON - An unruly passenger on a Frontier Airlines flight was seen on video yelling and being taken down by fellow ...
This platform accelerates the development of innovative biologics across four dimensions: new drug discovery, preclinical research, AI-assisted drug development, and frontier scientific research.